Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients

por Collins, Sean E., Grant, Philip M., Shafer, Robert W.
Publicado 2015

109. Preexisting Resistance and Week 48 Virologic Outcomes After Switching to B/F/TAF in African American Adults with HIV

por Andreatta, Kristen, D’Antoni, Michelle L, Chang, Silvia, Parvangada, Aiyappa, Blair, Christiana, Collins, Sean E, White, Kirsten L
Publicado 2020

629. High Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in African American Adults with HIV Including Those with Preexisting Resistance, Viral Blips, and Su...

por Andreatta, Kristen, D'Antoni, Michelle L, Chang, Silvia, Parvangada, Aiyappa, Martin, Ross, Blair, Christiana, Collins, Sean E, White, Kirsten L
Publicado 2021

Gender inequality and HIV transmission: a global analysis

por Richardson, Eugene T, Collins, Sean E, Kung, Tiffany, Jones, James H, Tram, Khai Hoan, Boggiano, Victoria L, Bekker, Linda-Gail, Zolopa, Andrew R
Publicado 2014

Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a “Low-Level” rpoB Mutation L511P – Insights into a Mechanism of R...

por Ocheretina, Oksana, Shen, Lishuang, Escuyer, Vincent E., Mabou, Marie-Marcelle, Royal-Mardi, Gertrude, Collins, Sean E., Pape, Jean W., Fitzgerald, Daniel W.
Publicado 2015

Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide

por Sax, Paul E., DeJesus, Edwin, Crofoot, Gordon, Ward, Douglas, Benson, Paul, Dretler, Robin, Mills, Anthony, Brinson, Cynthia, Wei, Xuelian, Collins, Sean E., Cheng, Andrew
Publicado 2018

Tuberculosis in the aftermath of the 2010 earthquake in Haiti

por Koenig, Serena P, Rouzier, Vanessa, Vilbrun, Stalz Charles, Morose, Willy, Collins, Sean E, Joseph, Patrice, Decome, Diessy, Ocheretina, Oksana, Galbaud, Stanislas, Hashiguchi, Lauren, Pierrot, Julma, Pape, Jean William
Publicado 2015

Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus

por Sax, Paul E, Rockstroh, Jürgen K, Luetkemeyer, Anne F, Yazdanpanah, Yazdan, Ward, Douglas, Trottier, Benoit, Rieger, Armin, Liu, Hui, Acosta, Rima, Collins, Sean E, Brainard, Diana M, Martin, Hal
Publicado 2020

1046. Week 48 Outcomes from the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in African American Adults with HIV

por Hagins, Debbie, Kumar, Princy, Saag, Michael, Wurapa, Anson K, Brar, Indira, Berger, Daniel, Osiyemi, Olayemi, Hileman, Corrilynn, Ramgopal, Moti, McDonald, Cheryl, Blair, Christiana, Andreatta, Kristen, Collins, Sean E, Brainard, Diana M, Martin, Hal
Publicado 2020

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study

por Hagins, Debbie, Kumar, Princy, Saag, Michael, Wurapa, Anson K., Brar, Indira, Berger, Daniel, Osiyemi, Olayemi, Hileman, Corrilynn O., Ramgopal, Moti N., McDonald, Cheryl, Blair, Christiana, Andreatta, Kristen, Collins, Sean E., Brainard, Diana M., Martin, Hal
Publicado 2021

Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials

por Orkin, Chloe, Ajana, Faiza, Kityo, Cissy, Koenig, Ellen, Natukunda, Eva, Gandhi-Patel, Bhumi, Wang, Hui, Liu, Yapei, Wei, Xuelian, White, Kirsten, Makadzange, Tariro, Pikora, Cheryl, McNicholl, Ian, Collins, Sean E., Brainard, Diana, Chuck, Susan K.
Publicado 2021

A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunode...

por Collins, Sean E., Grant, Philip M., Uwinkindi, Francois, Talbot, Annie, Seruyange, Eric, Slamowitz, Deborah, Mugeni, Adeline, Remera, Eric, Niyonsenga, Simon Pierre, Nyirimigabo, Josbert, Uwizihiwe, Jean Paul, Dongier, Pierre, Muhayimpundu, Ribakare, Mazarati, Jean-Baptiste, Zolopa, Andrew, Nsanzimana, Sabin
Publicado 2016

1002. A Daily Single Tablet Regimen (STR) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically-Suppressed Adults Living with HIV and End Stage Renal Diseas...

por Eron, Joseph J, Wilkin, Aimee, Ramgopal, Moti, Osiyemi, Olayemi, McKellar, Mehri, McKellar, Mehri, Slim, Jihad, Asmuth, David, DeJesus, Edwin, German, Polina, Blair, Christiana, Carter, Christoph C, Brainard, Diana M, Collins, Sean E, Martin, Hal
Publicado 2020

Long‐term mortality after tuberculosis treatment among persons living with HIV in Haiti

por Joseph, Yvetot, Yao, Zhiwen, Dua, Akanksha, Severe, Patrice, Collins, Sean E, Bang, Heejung, Antoine Jean‐Juste, Marc, Ocheretina, Oksana, Apollon, Alexandra, McNairy, Margaret L, Dupnik, Kathryn, Cremieux, Etienne, Byrne, Anthony, Pape, Jean W, Koenig, Serena P
Publicado 2021

High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I

por Sax, Paul E., Andreatta, Kristen, Molina, Jean-Michel, Daar, Eric S., Hagins, Debbie, Acosta, Rima, D’Antoni, Michelle L., Chang, Silvia, Martin, Ross, Liu, Hui, Blair, Christiana, McNicholl, Ian, Gallant, Joel, Collins, Sean E., Martin, Hal, White, Kirsten L.
Publicado 2022

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-bl...

por Mayer, Kenneth H, Molina, Jean-Michel, Thompson, Melanie A, Anderson, Peter L, Mounzer, Karam C, De Wet, Joss J, DeJesus, Edwin, Jessen, Heiko, Grant, Robert M, Ruane, Peter J, Wong, Pamela, Ebrahimi, Ramin, Zhong, Lijie, Mathias, Anita, Callebaut, Christian, Collins, Sean E, Das, Moupali, McCallister, Scott, Brainard, Diana M, Brinson, Cynthia, Clarke, Amanda, Coll, Pep, Post, Frank A, Hare, C Bradley
Publicado 2020